findmyKOL

Leon Herndon, MD

Enriched profile

Professor of Ophthalmology; Chief, Glaucoma Division · Duke University Eye Center

ORCIDNone on fileNPI
Region🇺🇸 Durham, NC · Southeast · United StatesSpecialtyOphthalmologyFocusGlaucoma
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2019Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Leon Herndon is Professor of Ophthalmology; Chief, Glaucoma Division at Duke University Eye Center. ClinicalTrials.gov lists 5 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 2 Sept 2026

Leon W. Herndon Jr., MD, is Professor of Ophthalmology at Duke University Eye Center / Duke University School of Medicine, Durham, NC. The public record shows 134 publications with 7,570 citations (h-index 39), centered on Glaucoma. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 18 companies.

  • Top research focus: Glaucoma
  • 5 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 18 companies

Generated from the cited public record · current as of 2 Sept 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Glaucoma4 trialsComa4 trialsRupture1 trialCataract1 trial

Research focus

OpenAlex concept fingerprint
Glaucoma

Drugs & molecules

across trials, industry payments and publications
Durystageneric · BimatoprostClinical trialsIndustry payments28PublicationsDextenzageneric · DexamethasoneClinical trialsIndustry payments5PublicationsTravoprostClinical trialsIndustry payments4Publications

Works with

trial sponsors and companies reporting payments
Alcon Vision LLCClinical trialsIndustry payments48Abbvie Inc.Clinical trialsIndustry payments38New World Medical,Inc.Clinical trialsIndustry payments27

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
39h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
5clinical trials

Investigator role on registered studies.

View trials
18companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 2 Sept 2026

Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 2 Sept 2026

18 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    85%
    Carbonic Anhydrase Inhibitor27.7%
    Dorzolamide-Timolol79%Dorzolamide Hcl9%Simbrinza5%Acetazolamide5%Brinzolamide2%
    Part D<11 patients
    Prostaglandin Analog25.8%
    Latanoprost88%Tafluprost7%Lumigan3%Travoprost3%
    Part D<11 patients
  • Cardiovascular

    7.8%
    Beta blocker7.8%
    Timolol Maleate100%
    Part D62 patients
  • Musculoskeletal

    2.8%
    Cyclooxygenase Inhibitor2.8%
    Ketorolac Tromethamine100%
    Part D45 patients
2 more therapeutic areas behind the reveal.Reveal →
Where care is delivered (Part B)8.8% facility · 91.2% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Online presence

Updated 2 Sept 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • LinkedIn

    linkedin.com/in/leon-herndon-91a98758

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com

Mentions by others

where others cite or feature them
  • X / Twitter

    x.com/dukeeyecenter/status/1811117256828436803

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com
  • YouTube

    youtube.com/watch

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com
2 more mentions behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 2 Sept 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • M.D.

    University of North Carolina at Chapel Hill School of Medicine

    1991
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.duke.edu
  • Board Certified

    American Board of Ophthalmology

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dukehealth.org
  • Residency in Ophthalmology

    University of North Carolina Hospitals, Chapel Hill, NC

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com
  • Clinical Fellowship in Glaucoma

    Duke University Medical Center, Durham, NC

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com

Editorial & leadership roles

journal and society appointments
  • President

    American Glaucoma Society (AGS), 2023-2024

    2024
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dukeeyecenter.duke.edu
  • Vice President

    American Glaucoma Society, 2022-2023

    2023
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dukeeyecenter.duke.edu
  • Founder

    North Carolina Glaucoma Club

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com
1 more role behind the reveal.Reveal →

Awards & honors

honors on the public record
1 more award behind the reveal.Reveal →

Media & interviews

press, podcasts and appearances
1 more media item behind the reveal.Reveal →

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.